Overview

Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

Status:
Completed
Trial end date:
2018-06-29
Target enrollment:
Participant gender:
Summary
The study is aimed at assessing the clinical follow-up and the outcomes of pregnancies exposed to ella, whether due to failure of the emergency contraception or inadvertent exposure during pregnancy.
Details
Lead Sponsor:
HRA Pharma